Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral Sclerosis

NCT05866926 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
201
Enrollment
INDUSTRY
Sponsor class

Stopped After the analysis of the main ADORE study it is concluded that there is no clinical benefit for the patients.

Conditions

Interventions

Sponsor

Ferrer Internacional S.A.